Only 25% of patients respond to sorafenib treatment, so researchers have endeavored to understand its mechanism of action and discover a way to boost its effectiveness.
from Top Health News – ScienceDaily http://ift.tt/2luXqoh
from Tumblr http://ift.tt/2mad1Xr
No comments:
Post a Comment